2,5-dihydroxybenzoic acid has been researched along with Idiopathic Parkinson Disease in 1 studies
2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martignoni, E | 1 |
| Blandini, F | 1 |
| Godi, L | 1 |
| Desideri, S | 1 |
| Pacchetti, C | 1 |
| Mancini, F | 1 |
| Nappi, G | 1 |
1 trial available for 2,5-dihydroxybenzoic acid and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.
Topics: Antiparkinson Agents; Biomarkers; Blood Platelets; Dopamine; Female; Gentisates; Humans; Hydroxybenz | 1999 |